Growth Metrics

Elanco Animal Health (ELAN) Net Income towards Common Stockholders (2017 - 2025)

Historic Net Income towards Common Stockholders for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$34.0 million.

  • Elanco Animal Health's Net Income towards Common Stockholders fell 10934.07% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year decrease of 8243.9%. This contributed to the annual value of $338.0 million for FY2024, which is 12745.74% up from last year.
  • Per Elanco Animal Health's latest filing, its Net Income towards Common Stockholders stood at -$34.0 million for Q3 2025, which was down 10934.07% from $11.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Net Income towards Common Stockholders peaked at $364.0 million during Q3 2024, and registered a low of -$1.1 billion during Q3 2023.
  • Over the past 5 years, Elanco Animal Health's median Net Income towards Common Stockholders value was -$50.0 million (recorded in 2024), while the average stood at -$74.2 million.
  • As far as peak fluctuations go, Elanco Animal Health's Net Income towards Common Stockholders soared by 17968.75% in 2022, and later tumbled by 158615.38% in 2023.
  • Elanco Animal Health's Net Income towards Common Stockholders (Quarter) stood at -$105.0 million in 2021, then surged by 48.57% to -$54.0 million in 2022, then crashed by 161.11% to -$141.0 million in 2023, then surged by 94.33% to -$8.0 million in 2024, then plummeted by 325.0% to -$34.0 million in 2025.
  • Its last three reported values are -$34.0 million in Q3 2025, $11.0 million for Q2 2025, and $67.0 million during Q1 2025.